Last viewed: GMDA


Prices are updated after-hours



nasdaq:GMDA Gamida Cell Ltd.

GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-34.8% 1m) (-57.1% 1y) (0.0% 2d) (0.0% 3d) (-5.2% 7d) (-58.29% volume)
Earnings Calendar: 2022-08-10
Market Cap: $ 105,559,851

http://www.gamida-cell.com
Sec Filling | Patents | 83 employees


Gamida Cell Ltd. is a clinical stage biopharmaceutical company engaging in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

cancer   israel   t-cell   ceiling  

add to watch list email alert is off

Press-releases


Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting
Published: 2022-09-29 (Crawled : 12:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 5.26% H: 11.87% C: 7.5%

blood for meeting trial
Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing
Published: 2022-09-28 (Crawled : 09:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: -22.84% H: 0.0% C: 0.0%

for
Movers & Shakers: New CEOs at 7 Biopharma Companies
Published: 2022-09-23 (Crawled : 12:00) - biospace.com/
SNY | $40.12 2.37% 0.05% | twitter stocktwits trandingview |
Health Technology
| | O: -1.69% H: 0.0% C: 0.0%
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: -3.82% H: 0.0% C: 0.0%

biopharma companies
Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies
Published: 2022-09-19 (Crawled : 12:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: -8.13% H: 0.0% C: 0.0%


Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting
Published: 2022-09-12 (Crawled : 13:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 2.26% H: 0.37% C: -1.48%

blood for meeting impact
Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update
Published: 2022-08-15 (Crawled : 12:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: -4.95% H: 9.77% C: 5.21%

update results
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201
Published: 2022-08-10 (Crawled : 12:00) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 22.01% H: 5.69% C: 3.53%

gda-201 candidate therapy study
Gamida Cell Announces the Date of Its Second Quarter 2022 Financial Results and Webcast
Published: 2022-08-08 (Crawled : 12:20) - biospace.com/
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 15.38% H: 0.0% C: 0.0%

results
FDA Weekly Review: Bayer, Daiichi Sankyo, AstraZeneca, Gamida Cell and More
Published: 2022-08-08 (Crawled : 23:00) - biospace.com/
JNJ | $165.62 1.48% -0.27% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 15.38% H: 0.0% C: 0.0%

fda
FDA Weekly Review: Gamida Cell, Cellectis, Scynexis and More
Published: 2022-08-06 (Crawled : 08:20) - biospace.com/
JNJ | $165.62 1.48% -0.27% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GMDA | $1.76 7.98% 1.7% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

fda
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Top 10 Gainers
VEV | $1.07 5.42% 59.81% | twitter stocktwits trandingview |
Manufacturing

HCKT | $19.22 4.86% 49.17% | twitter stocktwits trandingview |
Commercial Services

PEGY J | $1.43 79.69% 30.77% | twitter stocktwits trandingview |
Manufacturing

TOPS | $5.43 66.05% 25.23% | twitter stocktwits trandingview |
Transportation

AREB | $0.4294 19.28% 18.77% | twitter stocktwits trandingview |
Manufacturing

UNCY | $0.5559 -7.35% 16.93% | twitter stocktwits trandingview |
Professional, Scientific, and T...

SABS | $0.77 2.68% 16.88% | twitter stocktwits trandingview |

ALYA | $1.97 3.14% 16.5% | twitter stocktwits trandingview |
Technology Services

STSS 4 | $1.3 10.17% 16.15% | twitter stocktwits trandingview |
n/a

LIQT | $0.3901 0.54% 15.35% | twitter stocktwits trandingview |
Producer Manufacturing


Last 48 Hours Insiders Buying
UTG P 400 | $34.13 0% | twitter stocktwits trandingview |
Miscellaneous
| 18:00

12 months watchlist earnings calendar